An announcement from Nanosonics Limited ( (AU:NAN) ) is now available.
Nanosonics Limited announced a change in the director’s interest, with Director Tracey Leigh Batten acquiring an additional 15,715 ordinary shares, bringing her total to 30,000 shares. This transaction, valued at approximately $73,941.07, indicates a significant increase in her stake, potentially reflecting confidence in the company’s future performance.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection in healthcare settings.
YTD Price Performance: 41.71%
Average Trading Volume: 1,072
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $848M
See more data about NAN stock on TipRanks’ Stock Analysis page.